Inadequate dissemination of phase I trials: a retrospective cohort study
about
Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug TrialsWhy clinical translation cannot succeed without failureA deviation from standard design? Clinical trials, research ethics committees, and the regulatory co-construction of organizational devianceDelta inflation: a bias in the design of randomized controlled trials in critical care medicine.Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.Disease specific productivity of american cancer hospitalsClinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.gov.Occurrence and determinants of selective reporting of clinical drug trials: design of an inception cohort studyPatient enrollment and logistical problems top the list of difficulties in clinical research: a cross-sectional survey.Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines AgencyRisks of phase I research with healthy participants: A systematic reviewAssessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.Nonpublication of trial results for new neurological drugs: A systematic review.Characteristics and Dissemination of Phase 1 Trials Approved by a UK Regional Office in 2012.Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program.
P2860
Q28555016-B74D965E-E3E5-45B7-A00B-84A26BC1BD3DQ28607112-2E059D3F-D4B7-40CC-8577-0354CA2CC92DQ29303281-A4EDE104-8659-4BBB-B5D8-58E748BFC41EQ30435820-6246F10C-A5F1-4E4E-81A5-5DC3BC4829A8Q33659105-9E15E76A-5B36-4E4F-AACB-6B1A11747708Q35189592-E928CD44-40D8-4075-84D4-CAEE60CA6764Q35759905-632BC4DC-3BE2-477C-9CFC-641AC489A75FQ35844255-4D5B3F99-4FCF-43B7-8284-8082EAC7990CQ36008577-E618F778-293E-41FF-B2B1-51780968AB7CQ36367067-199B1DE1-0E8D-4676-99B4-8E9BA9847FC6Q36665273-9A210790-29A4-4C5C-B917-AB42393F6958Q36673516-F3D402E7-C327-4126-B1C1-063A0547B566Q38795557-B41C69A6-110E-43DC-8438-D32EB5573C17Q38808792-4E27C5D0-D22F-4958-9724-192A576A5A7FQ46698001-65517718-6EDA-4D75-8122-843E0CE2770B
P2860
Inadequate dissemination of phase I trials: a retrospective cohort study
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inadequate dissemination of phase I trials: a retrospective cohort study
@ast
Inadequate dissemination of phase I trials: a retrospective cohort study
@en
Inadequate dissemination of phase I trials: a retrospective cohort study
@nl
type
label
Inadequate dissemination of phase I trials: a retrospective cohort study
@ast
Inadequate dissemination of phase I trials: a retrospective cohort study
@en
Inadequate dissemination of phase I trials: a retrospective cohort study
@nl
prefLabel
Inadequate dissemination of phase I trials: a retrospective cohort study
@ast
Inadequate dissemination of phase I trials: a retrospective cohort study
@en
Inadequate dissemination of phase I trials: a retrospective cohort study
@nl
P2093
P2860
P3181
P1433
P1476
Inadequate dissemination of phase I trials: a retrospective cohort study
@en
P2093
An-Wen Chan
Evelyne Decullier
François Chapuis
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1000034
P407
P577
2009-02-17T00:00:00Z